Alterations in cyclin D-CDK4/6-Rb pathway such as CCND1 amplification can lead to uncontrolled tumor cell proliferation via sustained activation of CDK 4/6 and inactivation of Rb [55, 56]. Here, RB1 is linked to neoplasm.